Optimal Bilio-Pancreatic Limb (BPL) Length in One Anastomosis Gastric Bypass (OAGB) Surgery.

IF 9.5 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Current Obesity Reports Pub Date : 2025-01-25 DOI:10.1007/s13679-025-00608-0

G Balamurugan, Piriyah Sinclair, O Sesby-Banjoh, Mayuri Vinod, Yitka Graham, Kamal Mahawar

{"title":"Optimal Bilio-Pancreatic Limb (BPL) Length in One Anastomosis Gastric Bypass (OAGB) Surgery.","authors":"G Balamurugan, Piriyah Sinclair, O Sesby-Banjoh, Mayuri Vinod, Yitka Graham, Kamal Mahawar","doi":"10.1007/s13679-025-00608-0","DOIUrl":null,"url":null,"abstract":"Background: One Anastomosis Gastric Bypass (OAGB) is a modification of Mason's loop bypass procedure, which has become a well-established procedure in the field of Bariatric and Metabolic surgery (BMS). However, the optimal length of Biliopancreatic Limb (BPL) in OAGB remains an ongoing debate.Objective: This review aims to analyse the current trends and evidence regarding different BPL lengths in OAGB and their impact on outcomes.Methods: A comprehensive literature search using search terms, 'One Anastomosis Gastric Bypass', 'Mini-Gastric Bypass', 'Biliopancreatic Limb', and 'Small bowel limb' was conducted. The articles were extracted and critically appraised for various outcomes including weight loss, comorbidities resolution, nutritional deficiencies, complications and quality of life.Results: There appears to be a direct relationship between length of the BPL and the incidence of malnutrition. Longer BPL lengths (> 200 cm) are associated with a higher risk of malnutrition. Shorter BPL lengths (150-200 cm), particularly 150 cm, have shown promising outcomes.Conclusion: Shorter BPL lengths offer potential advantages by reducing nutritional risks associated with OAGB. Further research with long-term follow-up is needed to investigate the efficacy of even shorter BPL lengths (< 150 cm).","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":"14 1","pages":"14"},"PeriodicalIF":9.5000,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Obesity Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13679-025-00608-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background: One Anastomosis Gastric Bypass (OAGB) is a modification of Mason's loop bypass procedure, which has become a well-established procedure in the field of Bariatric and Metabolic surgery (BMS). However, the optimal length of Biliopancreatic Limb (BPL) in OAGB remains an ongoing debate.

Objective: This review aims to analyse the current trends and evidence regarding different BPL lengths in OAGB and their impact on outcomes.

Methods: A comprehensive literature search using search terms, 'One Anastomosis Gastric Bypass', 'Mini-Gastric Bypass', 'Biliopancreatic Limb', and 'Small bowel limb' was conducted. The articles were extracted and critically appraised for various outcomes including weight loss, comorbidities resolution, nutritional deficiencies, complications and quality of life.

Results: There appears to be a direct relationship between length of the BPL and the incidence of malnutrition. Longer BPL lengths (> 200 cm) are associated with a higher risk of malnutrition. Shorter BPL lengths (150-200 cm), particularly 150 cm, have shown promising outcomes.

Conclusion: Shorter BPL lengths offer potential advantages by reducing nutritional risks associated with OAGB. Further research with long-term follow-up is needed to investigate the efficacy of even shorter BPL lengths (< 150 cm).

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Obesity Reports Medicine-General Medicine

CiteScore

16.40

自引率

1.10%

发文量

期刊介绍： The main objective of Current Obesity Reports is to provide expert review articles on recent advancements in the interdisciplinary field of obesity research. Our aim is to offer clear, insightful, and balanced contributions that will benefit all individuals involved in the treatment and prevention of obesity, as well as related conditions such as cardiovascular diseases, endocrine disorders, gynecological issues, cancer, mental health, respiratory complications, and rheumatological diseases. We strive to redefine the way knowledge is expressed and provide organized content for the benefit of our readership.